| scholarly article | Q13442814 |
| P50 | author | Houria Boulaiz Tassi | Q75954051 |
| Carmen Griñán-Lisón | Q91282581 | ||
| Juan Antonio Marchal | Q37370058 | ||
| P2093 | author name string | Ana Martín | |
| Gema Jiménez | |||
| Alba Cambrils | |||
| Andrea Ibáñez Grau | |||
| Hoda Khaldy | |||
| Yaiza Jiménez-Martínez | |||
| P2860 | cites work | RASTA-Bacteria: a web-based tool for identifying toxin-antitoxin loci in prokaryotes | Q21184115 |
| Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells | Q24630262 | ||
| Mechanisms of drug resistance in colon cancer and its therapeutic strategies | Q26738528 | ||
| Viral vectors: a look back and ahead on gene transfer technology | Q26823087 | ||
| Toxin-based therapeutic approaches | Q27013664 | ||
| Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest | Q28206549 | ||
| Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. | Q50499408 | ||
| Mechanisms of Action and Cell Death Associated with Clostridium perfringens Toxins. | Q54203079 | ||
| 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression | Q58789473 | ||
| Drug development: Mix and match | Q59098616 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells | Q64084778 | ||
| Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin | Q64108076 | ||
| Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells | Q90860426 | ||
| Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo | Q90876771 | ||
| GLOBOCAN 2018: counting the toll of cancer | Q91841430 | ||
| Molecular characterization of long direct repeat (LDR) sequences expressing a stable mRNA encoding for a 35-amino-acid cell-killing peptide and a cis-encoded small antisense RNA in Escherichia coli | Q28214985 | ||
| Progress and problems with the use of suicide genes for targeted cancer therapy | Q28262370 | ||
| Improved Tet-responsive promoters with minimized background expression | Q33755382 | ||
| Divergently overlapping cis-encoded antisense RNA regulating toxin-antitoxin systems from E. coli: hok/sok, ldr/rdl, symE/symR. | Q34310279 | ||
| gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway | Q35600102 | ||
| Gene therapy for cancer: present status and future perspective | Q35673900 | ||
| Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter. | Q35813896 | ||
| Apoptosis and colorectal cancer | Q35915905 | ||
| Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy | Q36279105 | ||
| Broad targeting of resistance to apoptosis in cancer. | Q36483749 | ||
| Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer | Q36511054 | ||
| Frontiers in Suicide Gene Therapy of Cancer | Q36534930 | ||
| Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene. | Q36670856 | ||
| Tumor resistance to apoptosis | Q37323744 | ||
| Bacteria in cancer therapy: a novel experimental strategy | Q37717794 | ||
| Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for glioma | Q37730116 | ||
| Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. | Q37934486 | ||
| Mechanisms of Apoptin-induced cell death | Q37959247 | ||
| 3D cell culture systems: advantages and applications | Q38218818 | ||
| 3D tumor models: history, advances and future perspectives | Q38221694 | ||
| In vitro and in vivo anticancer activity of posterior salivary gland toxin from the cuttlefish Sepia pharaonis, Ehrenberg (1831). | Q38687012 | ||
| Cancer suicide gene therapy: a patent review. | Q38841046 | ||
| Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer | Q38915097 | ||
| Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy | Q39094451 | ||
| A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin | Q39114380 | ||
| LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells | Q39148218 | ||
| Clinical experience of treatment of metastatic melanoma and solid tumours adopting a derivative of diphtheria toxin: cross-reacting material 197. | Q40256912 | ||
| A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism | Q44976090 | ||
| Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle | Q45863122 | ||
| Cancer gene therapy by thyroid hormone-mediated expression of toxin genes | Q45868843 | ||
| Characterization of LdrA (long direct repeat A) protein of Escherichia coli | Q48354309 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 7 | |
| P921 | main subject | cancer gene therapy | Q124350675 |
| P577 | publication date | 2019-07-20 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy | |
| P478 | volume | 11 |
Search more.